The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular landscape and actionable alterations in a genomic-guided cancer clinical trial: First analysis of the ROME trial.
 
Andrea Botticelli
Honoraria - Amgen; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
 
Simone Scagnoli
Honoraria - Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
 
Pierfranco Conte
Consulting or Advisory Role - Daiichi Sankyo/Lilly; Gilead Sciences; Reveal Genomics
Speakers' Bureau - AstraZeneca Spain; Bristol-Myers Squibb; Lilly; Novartis; Roche; Tesaro
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - her2dx patent
Expert Testimony - AstraZeneca Spain; Roche
Travel, Accommodations, Expenses - AstraZeneca Spain; Celgene; Novartis; Pfizer
 
Chiara Cremolini
Honoraria - Amgen; Bayer; Merck; Merck; MSD; Pierre Fabre; Roche; SERVIER
Consulting or Advisory Role - Amgen; Bayer; MSD; Pierre Fabre; Roche
Speakers' Bureau - Merck; SERVIER
Research Funding - Bayer; Merck; Roche; SERVIER
 
Paolo Antonio Ascierto
Stock and Other Ownership Interests - PrimeVax
Consulting or Advisory Role - 4SC; Alkermes; Array BioPharma; AstraZeneca; Bio-AI Health; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Idera; Immunocore; Incyte; Italfarmaco; ITeos Therapeutics; Lunaphore Technologies; Medicenna; MedImmune; Merck Serono; Merck Sharp & Dohme; Nektar; Nouscom; Novartis; OncoSec; Pfizer; Pierre Fabre; Regeneron; Roche/Genentech; Sandoz; Sanofi; Seagen; Sun Pharma; Takis Biotech; Ultimovacs
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Federico Cappuzzo
Honoraria - AstraZeneca/MedImmune; Lilly; MSD Oncology; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly; MSD Oncology; pfizer; Roche/Genentech; Takeda
Travel, Accommodations, Expenses - OSE Immunotherapeutics
 
Massimo Aglietta
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - AstraZeneca (Inst); PharmaMar
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; MERCK; tesaro
 
Federica Mazzuca
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck; Novartis
Speakers' Bureau - Amgen; Bayer; Lilly; Merck; Novartis
 
Ettore Capoluongo
Honoraria - AstraZeneca/Daiichi Sankyo; GlaxoSmithKline; MSD
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; GlaxoSmithKline; MSD
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; GlaxoSmithKline; MSD
 
Giovanni Blandino
No Relationships to Disclose
 
Umberto Malapelle
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Diaceutics; GlaxoSmithKline; Lilly; Merck; MSD; Roche; Thermo Fisher Scientific
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Diaceutics; GlaxoSmithKline; Lilly; Merck; MSD; Roche; Thermo Fisher Scientific
 
Marianna Nuti
Research Funding - Incyte; Ipsen
 
Giulia D'Amati
Consulting or Advisory Role - Merck Sharp & Dohme; Roche
 
Bruna Cerbelli
Honoraria - Amgen (I); Bristol-Myers Squibb (I); Lilly (I); MSD (I); Novartis (I); Pfizer (I); Roche (I)
Consulting or Advisory Role - Amgen (I); Bristol-Myers Squibb (I); Lilly (I); MSD (I); Novartis (I); Pfizer (I); Roche (I)
 
Giancarlo Pruneri
Honoraria - Genomic Health; Novartis; Roche
Consulting or Advisory Role - ADS Biotec; ADS Biotec
Research Funding - Roche; Roche Molecular Diagnostics
 
Mauro Biffoni
No Relationships to Disclose
 
Giuseppe Giannini
No Relationships to Disclose
 
Francesco Cognetti
Honoraria - AstraZeneca Spain; GlaxoSmithKline
Consulting or Advisory Role - Dompé Farmaceutici; Genomic Health; GlaxoSmithKline; Lilly; Pfizer; Pierre Fabre; Roche; Seagen
Speakers' Bureau - AstraZeneca Spain; Genomic Health; Lilly; Pfizer; Pierre Fabre; Roche
 
Giuseppe Curigliano
Honoraria - Ellipses Pharma
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daichi-Sankyo; Foundation Medicine; GlaxoSmithKline; Guardant Health; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen
Speakers' Bureau - Daiichi Sankyo; Foundation Medicine; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche/Genentech
 
Paolo Marchetti
Honoraria - AstraZeneca/Daiichi Sankyo; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
Research Funding - Bristol-Myers Squibb; Incyte; Novartis; Pfizer; Roche; Takeda